This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q74132017
rdf:type
wikibase:Item
schema:description
klinisch onderzoek ensayu clínicu clinical trial клінічне випробування
rdfs:label
A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin
skos:prefLabel
A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin
schema:name
A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin
p:P1476
wds:Q74132017-0CAE9D55-369D-497C-971B-D692E466FBB9
wdt:P1476
The Effects of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on Insulin Sensitivity in Overweight and Obese Subjects With Hypertension
p:P31
wds:Q74132017-1BFDD29A-BE53-410B-BF65-5C41C6477180
wdt:P31
wd:Q30612
p:P580
wds:Q74132017-629E4854-AD28-4B64-B31A-40EC4AE72CCF
wdt:P580
2004-02-01T00:00:00Z
p:P17
wds:Q74132017-A14A0FF3-D817-439C-BD2D-FA2B02382E0D
wdt:P17
wd:Q30
p:P4844
wds:Q74132017-5410AC9F-B4F1-43A1-BB9D-046D82F126FE wds:Q74132017-B14536AE-0BA7-46D1-8EC5-6782CD9A876F
wdt:P4844
wd:Q410074 wd:Q7700570
p:P2899
wds:Q74132017-DD2B124A-17C9-41D5-B573-E0A1E823AFCB
wdt:P2899
18
p:P1050
wds:Q74132017-13FFF48B-CDFD-41A6-88C0-22065806FF45 wds:Q74132017-2172E51A-A881-4525-AD81-D7D29D38DD28 wds:Q74132017-F9088813-13E7-4916-8E5B-2DC7E9D308AA
wdt:P1050
wd:Q657193 wd:Q41861 wd:Q332428
p:P1132
wds:Q74132017-2A6E2535-1A35-446E-9DC1-2FB7B8B37A24
wdt:P1132
60
p:P4135
wds:Q74132017-F293C3EB-034E-44E3-9295-E159C3C2592A
wdt:P4135
75
p:P8363
wds:Q74132017-11AA553A-6942-452D-AFEC-4F7788289EC8
wdt:P8363
wd:Q78089383
p:P3098
wds:Q74132017-C5044DF0-05FE-4099-846B-F1344DA35E16
wdt:P3098
NCT00185094
p:P6099
wds:Q74132017-709752F5-D19A-4B31-8228-BE11BD3DCDF6
wdt:P6099
wd:Q42825046